Literature DB >> 21503948

Mixtures of multiple testing procedures for gatekeeping applications in clinical trials.

Alex Dmitrienko1, Ajit C Tamhane.   

Abstract

This paper proposes a general framework for constructing gatekeeping procedures for clinical trials with hierarchical objectives. Such problems frequently exhibit complex structures including multiple families of hypotheses and logical restrictions. The proposed framework is based on combining multiple procedures across families. It enables the construction of powerful and flexible gatekeeping procedures that account for general logical restrictions among the hypotheses of interest. A clinical trial in patients with schizophrenia is used to illustrate the approach for parallel gatekeeping, whereas another clinical trial in patients with hypertension is used to illustrate the approach for gatekeeping with general logical restrictions.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503948     DOI: 10.1002/sim.4008

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

1.  Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults.

Authors:  Dennis T Villareal; Lina Aguirre; A Burke Gurney; Debra L Waters; David R Sinacore; Elizabeth Colombo; Reina Armamento-Villareal; Clifford Qualls
Journal:  N Engl J Med       Date:  2017-05-18       Impact factor: 91.245

2.  Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial.

Authors:  Yu Hong Chen; Chien-Ning Huang; Young Min Cho; Pengfei Li; Liqun Gu; Feng Wang; Jun Yang; Wei Qing Wang
Journal:  Diabetes Obes Metab       Date:  2018-06-05       Impact factor: 6.577

3.  A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms.

Authors:  Katy Bernard; Sylvie Gouttefangeas; Sylvie Bretin; Stéphanie Galtier; Philippe Robert; Vjera Holthoff-Detto; Jeffrey Cummings; Maria Pueyo
Journal:  Alzheimers Dement (N Y)       Date:  2019-06-24

4.  Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).

Authors:  Maggie Fedgchin; Madhukar Trivedi; Ella J Daly; Rama Melkote; Rosanne Lane; Pilar Lim; Dawn Vitagliano; Pierre Blier; Maurizio Fava; Michael Liebowitz; Arun Ravindran; Raphael Gaillard; Hans Van Den Ameele; Sheldon Preskorn; Husseini Manji; David Hough; Wayne C Drevets; Jaskaran B Singh
Journal:  Int J Neuropsychopharmacol       Date:  2019-10-01       Impact factor: 5.176

5.  Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial.

Authors:  Christoph U Correll; Robert E Davis; Michal Weingart; Jelena Saillard; Cedric O'Gorman; John M Kane; Jeffrey A Lieberman; Carol A Tamminga; Sharon Mates; Kimberly E Vanover
Journal:  JAMA Psychiatry       Date:  2020-04-01       Impact factor: 21.596

6.  Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study.

Authors:  Li Xin Shi; Xiao Min Liu; Yong Quan Shi; Quan Min Li; Jian Hua Ma; Yan Bing Li; Li Ying Du; Feng Wang; Lu Lu Chen
Journal:  J Diabetes Investig       Date:  2019-06-13       Impact factor: 4.232

7.  Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.

Authors:  Davey Daniel; Vladimer Kuchava; Igor Bondarenko; Oleksandr Ivashchuk; Sreekanth Reddy; Jana Jaal; Iveta Kudaba; Lowell Hart; Amiran Matitashvili; Yili Pritchett; Shannon R Morris; Jessica A Sorrentino; Joyce M Antal; Jerome Goldschmidt
Journal:  Int J Cancer       Date:  2020-12-21       Impact factor: 7.396

8.  Calorie restriction improves lipid-related emerging cardiometabolic risk factors in healthy adults without obesity: Distinct influences of BMI and sex from CALERIE™ a multicentre, phase 2, randomised controlled trial.

Authors:  Kim M Huffman; Daniel C Parker; Manjushri Bhapkar; Susan B Racette; Corby K Martin; Leanne M Redman; Sai Krupa Das; Margery A Connelly; Carl F Pieper; Melissa Orenduff; Leanna M Ross; Megan E Ramaker; James L Dorling; Clifford J Rosen; Irina Shalaurova; James D Otvos; Virginia B Kraus; William E Kraus
Journal:  EClinicalMedicine       Date:  2022-01-03

9.  An Application of Graphical Approach to Construct Multiple Testing Procedures in a Hypothetical Phase III Design.

Authors:  Bushi Wang; Naitee Ting
Journal:  Front Public Health       Date:  2014-01-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.